drugset / Trial / NCT02011542

Probiotic (VSL #3) for Gulf War Illness

NCT02011542

RandomizedParallel-groupTriple-blindTreatment

Summary

The overall objective is to determine whether VSL #3 will improve 1) intestinal symptoms of Irritable Bowel Syndrome (IBS) and 2) non-intestinal symptoms (fatigue, joint pain, insomnia, general stiffness and headache) associated with IBS. All of these symptoms are part of the Gulf War (GW) illness.

Timeline

Start
2013-09
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator VSL#3 Other / unclassified

Indications